• Increase font size
  • Default font size
  • Decrease font size
Information for citizens
Information for medical specialists
Information for companies
Home Warnings
Information for citizens

EMA to review persistence of side effects known to occur with quinolone and fluoroquinolone antibiotics

Review to focus on long-lasting effects mainly affecting musculoskeletal and nervous systems

The European Medicines Agency (EMA) is reviewing systemic and inhaled quinolone and fluoroquinolone antibiotics to evaluate the persistence of serious side effects mainly affecting muscles, joints and the nervous system. These side effects are of particular importance when the medicines are used for less severe infections.

More detailed information on:

EMA to review persistence of side effects known to occur with quinolone and fluoroquinolone antibiotics

 
Top